Startups
Jiuzhou Pharmaceutical offers one-stop innovative drug research and production services, such as CDMO Pharma, API Manufacturing, Topical Formulation, Small molecule drug, etc
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 25, 2025 | JiuZhou Pharma Wins 25th China Patent Exellence Award | JiuZhou Pharma's New China Patent Excellence Award Certificate Invention Patent Supports Tumor Treatment Development and Accessibility Zhejiang JiuZhou Pharmaceutical Co Ltd (SSE:603456.SH) Asymmetric Hydrogenation Reaction of α-Keto Acid C... |
| Oct 15, 2024 | Jiuzhou Pharma Welcomes Kathleen Noack as Vice President of Business Development | Kathleen Noack, VP of Tides Business Development at Jiuzhou Pharma Global Strategy for Peptide and Conjugate Drug Processes Her extensive expertise in business development and proven track record in the peptide industry will be critical as ... |
| Jun 13, 2024 | Jiuzhou Pharma Appoints Industry Leader Mike Pennington as Global Head of TIDES | Dr. Mike Pennington, Global Head of Peptides and Oligonucleotides, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Global Plans for Peptide and Conjugate Drug Processes He has both the leadership experience and technical background to be immediat... |
Reviews 0
FAQ about Jiuzhou Pharma
What has the press written about Jiuzhou Pharma?
Parsers VC has collected 4 articles mentioning Jiuzhou Pharma, among them “JiuZhou Pharma Wins 25th China Patent Exellence Award” (Jun 25, 2025) and “Jiuzhou Pharma Welcomes Kathleen Noack as Vice President of Business Development” (Oct 15, 2024).
Is Jiuzhou Pharma still active?
Yes, Jiuzhou Pharma is active; its latest activity on Parsers VC dates from Jul 22, 2026.